608 results found for 'abo'

Extended temozolomide chemotherapy period for glioblastoma Research study

A clinical trial to determine if extending temozolomide treatment (chemotherapy) after radiation improves survival in patients with newly diagnosed glioblastoma.

https://www.thermh.org.au/research/clinical-trials-research-studies/extended-temozolomide-chemotherapy-period-for-glioblastoma

Antipsychotic dose reduction to improve recovery and function in young people with psychosis Research study

The REDUCE study is testing whether reducing the dosage of antipsychotic medication of people recovering from their first episode of psychosis can lead to them having better recovery outcomes.

https://www.thermh.org.au/research/clinical-trials-research-studies/antipsychotic-dose-reduction-to-improve-recovery-and-function-in-young-people-with-psychosis

Our research

The RMH Kidney Care service is strongly committed to improvement through research and innovation. We have shown that ongoing research and quality initiatives lead to tangible improvements in clinical outcomes.

https://www.thermh.org.au/services/kidney-care/kidney-care-research

Narcolepsy

Narcolepsy is a rare neurological disorder where the part of the brain that controls falling asleep functions abnormally.

https://www.thermh.org.au/services/respiratory-medicine-sleep-disorders/learn-about/sleep-studies-and-disorders/narcolepsy

Mental health learning and development

Our Mental Health Learning and Development Program enhances the skills, knowledge and capabilities of our people so they can deliver high-quality care and support to individuals experiencing mental health issues, as well as to their families, carers, supporters and kin.

https://www.thermh.org.au/health-professionals/training-courses/mental-health-learning-development-program

Dr Kate Martin recognised in 26 January Honours News article

Congratulations to Kate Martin AM who was recognised at the 26 January Honours.

https://www.thermh.org.au/news/dr-kate-martin-recognised-in-26-january-honours

ANAVEX®2-73 for mild cognitive impairment or early Alzheimer’s disease Research study

 A clinical trial that aims to assess the safety and efficacy of a new drug (ANAVEX®2-73) for the treatment of early Alzheimer’s disease.

https://www.thermh.org.au/research/clinical-trials-research-studies/anavex-2-73-mild-cognitive-impairment-or-early-alzheimers-disease

Amlitelimab (KY1005) for moderate to severe atopic dermatitis Research study

A clinical trial to assess a new drug called amlitelimab (KY1005) as a treatment for moderate to severe atopic dermatitis (eczema)

https://www.thermh.org.au/research/clinical-trials-research-studies/amlitelimab-ky1005-for-moderate-to-severe-atopic-dermatitis

ICU medical careers and education

The Royal Melbourne Hospital (RMH) ICU employs intensive care specialists, registrars and residents. We are accredited for training for neurological/neurosurgical, cardiothoracic and trauma ICU requirements.

https://www.thermh.org.au/services/intensive-care/work-with-icu/icu-medical-careers-education

Clinical Haematology RMH Service

We are one of Victoria's largest providers of cancer care and treatment, caring for more than 37,000 patients each year.

https://www.thermh.org.au/services/clinical-haematology

Advanced Interventions in Mood Disorders Clinic

The Advanced Interventions in Mood Disorders (AIM) Clinic provides adults with severe mood disorders access to novel treatments and innovative research projects.

https://www.thermh.org.au/services/mental-health/our-research/advanced-interventions-in-mood-disorders

Staff benefits

We have a range of initiatives to support employees in their work, as well as to recognise the achievements and contributions of individuals and teams.

https://www.thermh.org.au/health-professionals/careers/why-work-at-the-rmh/staff-benefits

Combination treatment for locally advanced or metastatic ER-positive breast cancer Research study

A phase II, multicentre, randomised study to compare the efficacy of venetoclax plus fulvestrant as a combination treatment for locally advanced or metastatic ER-positive breast cancer.

https://www.thermh.org.au/research/clinical-trials-research-studies/combination-treatment-for-locally-advanced-or-metastatic-er-positive-breast-cancer

Geographic atrophy from age-related macular degeneration Research study

The Golden trial is a study of a potential new treatment referred to as ISIS 696844 to determine its safety and effectiveness in slowing the progression of geographic atrophy (GA) caused by age-related macular degeneration (AMD).

https://www.thermh.org.au/research/clinical-trials-research-studies/golden-trial-geographic-atrophy-from-age-related-macular-degeneration

The RMH partners with Australian Centre for Accelerating Diabetes Innovations News article

A national diabetes research centre initiative involving the Royal Melbourne Hospital has been funded through a significant Australian Government grant.

https://www.thermh.org.au/news/the-rmh-partners-with-australian-centre-for-accelerating-diabetes-innovations

Protect yourself from measles - visit the RMH Measles Monday Clinic News article

The RMH’s pop-up Measles Monday Clinic is open again on Monday so staff and the public can get up-to-date with their measles vaccinations - for free!

https://www.thermh.org.au/news/protect-yourself-from-measles-visit-the-rmh-measles-monday-clinic
17 18 19 20 21 22 23 24 25